GROUP ONE TRADING, L.P. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330909. A total of 3 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$709,993
-22.9%
61,900
+70.1%
0.00%
-33.3%
Q2 2023$921,284
+42.3%
36,400
+81.1%
0.00%
+50.0%
Q1 2023$647,421
-26.2%
20,100
-57.7%
0.00%0.0%
Q4 2022$876,850
-76.1%
47,500
-65.0%
0.00%
-71.4%
Q3 2022$3,669,000
+902.5%
135,900
+412.8%
0.01%
+600.0%
Q2 2022$366,000
-5.7%
26,500
+33.2%
0.00%
Q1 2022$388,000
+47.5%
19,900
+23.6%
0.00%
Q4 2021$263,000
-80.9%
16,100
-67.3%
0.00%
-100.0%
Q3 2021$1,374,000
+487.2%
49,300
+524.1%
0.00%
Q2 2021$234,000
+420.0%
7,900
+393.8%
0.00%
Q1 2021$45,000
-95.6%
1,600
-95.6%
0.00%
-100.0%
Q4 2020$1,032,000
+752.9%
36,400
+658.3%
0.00%
Q3 2020$121,000
-53.3%
4,800
-54.7%
0.00%
-100.0%
Q2 2020$259,000
+149.0%
10,600
+51.4%
0.00%0.0%
Q1 2020$104,000
+1200.0%
7,000
+1300.0%
0.00%
Q4 2019$8,000
-98.2%
500
-98.5%
0.00%
-100.0%
Q3 2019$434,000
+5325.0%
33,400
+6580.0%
0.00%
Q1 2019$8,0000.0%500
+25.0%
0.00%
Q4 2018$8,000
-98.4%
400
-98.0%
0.00%
-100.0%
Q3 2018$492,000
+60.3%
19,800
+76.8%
0.00%
+33.3%
Q2 2018$307,000
+60.7%
11,200
+80.6%
0.00%
+50.0%
Q1 2018$191,000
-72.2%
6,200
-67.7%
0.00%
-60.0%
Q4 2017$686,000
+8475.0%
19,200
+6300.0%
0.01%
Q3 2017$8,0000.0%3000.0%0.00%
Q2 2017$8,0000.0%300
-25.0%
0.00%
Q1 2017$8,000
+300.0%
400
+300.0%
0.00%
Q3 2016$2,000
-93.1%
100
-95.2%
0.00%
Q2 2016$29,000
-23.7%
2,100
-4.5%
0.00%
-100.0%
Q1 2016$38,000
-84.4%
2,200
-69.0%
0.00%
-66.7%
Q4 2015$243,000
+25.9%
7,100
+9.2%
0.00%0.0%
Q3 2015$193,000
+9.7%
6,500
+18.2%
0.00%
+50.0%
Q2 2015$176,000
+102.3%
5,500
+31.0%
0.00%
+100.0%
Q1 2015$87,0004,2000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 36,400$1,032,0000.00%
SIMPLEX TRADING, LLC 226$640,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REVANCE THERAPEUTICS INC shareholders